Das Medizinportal     Aktuelles für medizinische Fachkreise
Menü

Das Medizinportal     Aktuelles für medizinische Fachkreise

Literatur:

Kardiovaskuläre Risikostratifikation und Früherkennung

Uwe Nixdorff

  1. World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization, 2008.
  2. Dawber TR, Kannel WB. An epidemiologic study of heart disease: the Framingham study. Nutr Rev 1958; 16: 1–4.
  3. Perk J1, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation [EACPR]; ESC Committee for Practice Guidelines [CPG]. European Guidelines on cardiovascular disease prevention in clinical practice [version 2012]. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice [constituted by representatives of nine societies and by invited experts]. Eur Heart J 2012; 33: 1635–701.
  4. Hobbs FD, Jukema JW, Da Silva PM, McCormack T, Catapano AL. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM 2010; 103: 727-739. 
  5. Liew S M, Doust J, Glasziou P. Cardiovascular risk scores do not account for the effect of treatment: a review. Heart 2011; 97: 689-697.
  6. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk. A review for clinicians. J Am Coll Cardiol 2009; 54: 1209–27.
  7. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837–1847.
  8. Lloyd-Jones DM. Cardiovascular risk prediction. Basic concepts, current status, and future directions. Circulation 2010; 121; 1768–1777.
  9. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS guidelines for the management of dyslipidemias. The Task Force for the management of dyslipidemias of the European Society of Cardiology [ESC] and the European Atherosclerosis Society [EAS]. Eur Heart J 2011; 32: 1769–1818.
  10. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2010; 122: e584–e636.
  11. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster [PROCAM] study. Circulation 2002; 105: 310 –5.
  12. Grundy SM, Cleeman JI, Merz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ for the coordinating committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–239.
  13. Pepe MS, Janes H, Longton G, Leisering W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159: 882–890.
  14. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157–172.
  15. Empana JP, Ducimetière P, Arveiler D, Ferrières J, Evans A, Ruidavets JB, Haas B, Yarnell J, Bingham A, Amouyel P, Dallongeville J; PRIME Study Group.. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME  study. Eur Heart J 2003; 24: 1903–11.
  16. Scheltens T, Verschuren WM, Boshuizen HC, Hoes AW, Zuithoff NP, Bots ML, Grobbee DE. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age. Eur J Cardiovasc Prev Rehabil 2008; 15: 562–6.
  17. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 2008; 94: 34–9.
  18. Volpe M, Battistoni A, Tocci G, Agabiti Rosei E, Catapano AL., Coppo R, del Prato S, Gentile S, Mannarino E, Novo S, Prisco D, Mancia G. Cardiovascular risk assessment beyond systemic coronary risk estimation: a role for organ damage markers. J Hyperten 2012, 30: 1056–1064.
  19. Wang TJ. New cardiovascular risk factors exist, but are they clinically useful? Eur Heart J 2008; 29: 441–444.
  20. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL. Emerging Risk Factors for Coronary Heart Disease: a summary of systematic reviews conducted for the U.S. preventive services task force. Ann Intern Med 2009; 151: 496–507.
  21. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557–65.
  22. Koenig W, Ridker PM. Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ?5% or Framingham risk > 20 %:post hoc analyses of the JUPITER trial requested by European health authorities. Eur Heart J 2011; 32: 75–83.
  23. Wang TJ. Heart Protection Study collaborative group. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20536 patients in the Heart Protection Study. Lancet 2011; 377: 469–76. 
  24. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Wu KK, Boerwinkle E, Mosley TH Jr, Sorlie P, Diao G, Sharrett AR. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the Atherosclerosis Risk In Communities study. Arch Intern Med 2006; 166: 1368–1373.
  25. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302: 49–57.
  26. The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132–40.
  27. Bennet A, Di AE, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M, Rumley A, Lowe GD, Danesh J, Gudnason V. Lipoprotein[a] levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med 2008; 168: 598–608. 
  28. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A; European Atherosclerosis Society Consensus Panel. Lipoprotein[a] as a cardiovascular risk factor: current status. Eur Heart J 2010; 31: 2844–53.
  29. Garza CA, Montori VM, McConnell JP, Somers VK, Kullo IJ, Lopez-Jimenez F. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc 2007; 82: 159–65.
  30. The Lp-PLA2 Studies Collaboration. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 2010; 375: 1535–44.
  31. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study [AMORIS]. Atherosclerosis 2010; 213: 299–305. 
  32. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631–9.
  33. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Basu S, Larsson A, Venge P, Arnlöv J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358: 2107–16.
  34. Kavousi M, Elias-Smale S, Rutten JHW, Leening MJG, Vliegenhart R, Verwoert GC, Krestin GP, Oudkerk M, de Maat MP, Leebeek FW, Mattace-Raso FU, Lindemans J, Hofman A, Steyerberg EW, van der Lugt A, van den Meiracker AH, Witteman JC. Evaluation of newer risk markers for coronary heart disease risk classification. A cohort study. Ann Intern Med 2012; 156: 438–44.
  35. Shah PK. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol 2010; 56: 98–105.
  36. Amann U, Kirchberger I, Heier M, Golüke H, von Scheidt W, Kuch B, Peters A, Meisinger C. Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry. Clin Res Cardiol 2014; 103: 655–64.
  37. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk the ARIC [Atherosclerosis Risk In Communities] study. J Am Coll Cardiol 2010; 55: 1600–7.
  38. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011; 365:213-21.
  39. Peters SAE, den Ruijter HM, Bots ML, Moons KGM. Improvements in risk stratification for the occurence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012; 98: 177.84.
  40. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima-media thickness task force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21: 93–111.
  41. Junyent M, Zambon D, Gilabert R, Nunez I, Cofan M, Ros E. Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score. Atherosclerosis 2008; 196: 803–9.
  42. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA, Viigimaa M, Zanchetti A. European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension task force document. J Hypertens. 2009; 27: 2121–58.
  43. Giannarelli C, Ibanez B,Cimmino G, Garcia Ruiz JM., Faita F, Bianchini E, Zafar MU, Fuster V, Garcia MJ, Badimon JJ. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. J Am Coll Cardiol Cardiovascular Imaging 2010; 3: 1256–64.
  44. Fowkes GF, and the Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197–200.
  45. Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev 2007; 2: CD002945.
  46. Lim LS, Haq N, Mahmood S, Hoeksema L, and the ACPM Prevention Practice Committee. Atherosclerotic cardiovascular disease screening in adults American College of Preventive Medicine position statement on preventive practice. Am J Prev Med 2011; 40: 380–1.
  47. Søgaard R, Laustsen J, Lindholt JS. Cost effectiveness of abdominal aortic aneurysm screening and rescreening in men in a modern context: evaluation of a hypothetical cohort durign a decision analytical model. BMJ 2012; 345: e4276.
  48. Barasch E, Gottdiener JS, Larsen EK, Chaves P, Newman AB, Manolio TA. Clinical significance of calcification of the fibrous skeleton of the heart and aorto-sclerosis in community dwelling elderly. The Cardiovascular Healthy Study. Am Heart J 2006; 151: 39–47.
  49. Kanjanauthai S, Nasir K, Katz R, Rivera JJ, Takasu J, Blumenthal RS, Eng J, Budoff MJ. Relationship of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis [MESA]. Atherosclerosis 2010; 213: 558–62.
  50. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V, Agabiti-Rosei E, Mancia G. Reliability and limitations of measurement of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: The RES trial. J Hypertens 1999; 17: 1955–63.
  51. Mark DB, Berman DS, Budoff MJ, Carr JJ, Gerber TC, Hecht HS, Hlatky MA, Hodgson JM, Lauer MS, Miller JM, Morin RL, Mukherjee D, Poon M, Rubin GD, Schwartz RS. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography. A report of the American College of Cardiology Foundation task force on expert consensus documents. J Am Coll Cardiol 2010; 55: 2663–99.
  52. Gottlieb I, Miller JM, Arbab-Zadeh A, Dewey M, Clouse ME, Sara L, Niinuma H, Bush DE, Paul N, Vavere AL, Texter J, Brinker J, Lima JA, Rochitte CE. The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol 2010; 55: 627–34.
  53. Budoff MJ, Shaw LJ, Liu S T, Weinstein SR, Mosler TP, Tseng PH, Flores FR, Callister TQ, Raggi P, Berman DS. Long-term prognosis associated with coronary calci?cation observations from a registry of 25,253 patients. J Am Coll Cardiol 2007; 49: 1860–70.
  54. Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffman U, Cury RC, Abbara S, Brady TJ, Budoff MJ, Blumenthal RS, Nasir K. Diagnostic and prognostic value of absence of coronary artery calci?cation. J Am Coll Cardiol Img 2009; 2: 675–88.
  55. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010; 303: 1610–6.
  56. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bröcker-Preuss M, Mann K, Siegrist J, Jöckel KH; Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination,  and reclassification improvement based on quantification of subclinical coronary atherosclerosis. The Heinz Nixdorf Recall Study. J Am Coll Cardiol 2010; 56: 1397–406.
  57. Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, Conroy R, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham I; SCORE Investigators. How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators. Eur J Cardiovasc Prev Rehabil 2009; 16: 304–14.
  58. Cook NR, Buring JE, Ridker PM. The effect of including CRP in cardiovascular risk prediction models for women. Ann Intern Med 2006; 145: 21–9.
  59. Wilson PW, Pencina M, Jacques P, Selhub J, D’Agostino R Sr., O’Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008; 1: 92–7.
  60. Simmons RK, Sharp S, Boekholdt SM, Sargeant LA, Khaw KT, Wareham NJ, Griffin SJ. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? Arch Intern Med 2008; 168: 1209–16.
  61. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines T, Berman DS; CONFIRM Investigators. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM [Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry] of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 2011; 58: 849–60
  62. Villines TC, Hulten EA, Shaw LJ, Goyal M, Dunning A, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Lin FY, Maffei E, Raff GL, Min JK; CONFIRM Registry Investigators. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM [Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter] registry. J Am Coll Cardiol 2011; 58: 2533–40.
  63. Takya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, Tran N, Polissar NL, Isaac C, Ferguson MS, Garden GA, Cramer SC, Maravilla KR, Hashimoto B, Hatsukami TS. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI. Initial results. Stroke 2006; 37: 818–3.
  64. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner K, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T; ESC Committee for Practice Guidelines. ESC committee for practice Guidelines. ESC Guideline on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerosis disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology [ESC]. Eur Heart J 2011; 32: 2851–6.
  65. Agabiti Rosei E, de Simone G, Mureddu GF, Trimarco B,  Verdecchia P, Volpe M. for the Joint Committee of the Italian Society of Hypertension [SIIA], Italian Society of Cardiology [SIC], Associazione Nazionale Medici Cardiologi Ospedalieri [ANMCO]. Arterial hypertension and cardiac damage: diagnostic and therapeutic guidelines. High Blood Press Cardiovasc Prev 2008; 15: 141–169.
  66. Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, Mureddu G, Pede S, Maggioni AP, Lucci D, Reboldi G; Cardio-Sis investigators on behalf of the Cardio-Sis investigators. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension [Cardio-Sis]: an open-label randomized trial. Lancet 2009; 374: 525–33.
  67. Okin P, Deveraux R, Jern S, Kjeldsen SE, Julius S, Niemine MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B; LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004; 292: 2343–9.
  68. Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, Michelson G, Schmieder RE. Increased wall/lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension 2007; 50: 623–829. 
  69. Erbel R, Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J 2012; 33: 1201–17.

MyHeartCoach

Helmut Gohlke, Andreas Hoffmann, Uwe Blessberger, Wolfgang Bachmann

 

  1. Freisinger E, Fuerstenberg T, Malyar NM, Wellmann J, Keil U, Breithardt G, and Reinecke H. German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life European Heart Journal (2014) 35, 979–988
  2. Gohlke H Prävention durch Lebensstiländerung: Was ist gesichert? Herz 2004; 29: 139–44
  3. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MS, Sacco RL. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke,and vascular death across whites, blacks, and Hispanics: the Northern Manhattan Study.Circulation. 2012; 125: 2975–2984
  4. Mokdad AH1, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004: 291: 1238–45.
  5. Yusuf S, Hawken S,Oˆ unpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937–952.
  6. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP,and Lloyd-Jones DM Lifetime Risks of Cardiovascular Disease , N Engl J Med 2012; 366: 321–9.
  7. Yates LB,Djousse L,Kurth T,Buring JE,Gaziano JM  Exceptional longevity in men  Archives Intern Med 2008; 168: 284–290
  8. Åkesson A, Larsson SC, Discacciati A, Wolk A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study. J Am Coll Cardiol 2014; 64: 1299–1306
  9. Chiuve SE,McCullough ML, Sacks FM,Rimm EB Healthy Lifestyle Factors in the Primary Prevention of Coronary Heart Disease among Men; Benefits among Users and Nonusers of Lipid-Lowering and Antihypertensive Medication Circulation. 2006; 114:160–167
  10. Chow CK, Jolly S, Rao-Melacini P, Fox KAA, Anand SS, Yusuf S Association of Diet,Exercise,and Smoking Modification with Risk of early CV Events after Acute Coronary Syndromes Circulation. 2010; 121: 750–758
  11. Gohlke H Kann man durch Prävention Geld sparen? Kardiologie up to date 2008; 4: 201–205 
  12. DeutscheHerzstiftung:http://www.herzstiftung.de/Herzinfarkt-Risiko-Test.php?et_cid=10&et_lid=27084&et_sub=Hif-Risiko-Test_ueber_Startseiten-Link 
  13. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K and Keil U on behalf of the EUROASPIRE Study Group  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries  Eur J Cardiovasc Prev Rehabil 2009; 16: 121–137 
  14. Bauman A, Armstrong T, Davies J, Owen N, Brown W, Bellew B, Vita P.Trends in physical activity participation and the impact of integrated campaigns among Australian adults, 1997–99. AustNew Zealand J Publ Health. 2003; 27: 76–79.
  15. Snyder LB, Hamilton MA, Mitchell EW, Kiwanuka-Tondo J, Fleming-Milici F, Proctor D. A Meta-Analysis of the Effect of Mediated Health Communication Campaigns on Behavior Change in the United States. J Health Comm. 2004; 9: 71–96.
  16. Cobb SL, Brown DJ, Davis LL. Effective interventions for lifestyle change after myocardial infarction or coronary artery revascularization. J Am Nurse Pract. 2006; 18: 31–39.
  17. Moore SM, Charvat JM, Gordon NH, Pashkov F, Ribisl P, Roberts BL,Rocco M. Effects of a CHANGE intervention to increase exercise maintenance following cardiac events. Ann Behav Med. 2006; 31: 53–62.
  18. LeFevre ML on behalf of the U.S. Preventive Services Task Force Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement.  Ann Intern Med. 2014; 161(8): 587–593
  19. Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008; 8: 38.
  20. Prior M, Guerin M, Grimmer-Somers K. The effectiveness of clinical guideline implementation strategies: a synthesis of systematic review findings. J Eval Clin Pract. 2008; 14: 888–897. 
  21. Williams JB, Delong ER, Peterson ED, Dokholyan RS, Ou FS, Ferguson TB Jr. Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice. Circulation 2011; 123: 39–45.
  22. Arrigo I, Brunner-LaRocca HP, Lefkovits M, Pfisterer M, Hoffmann A. Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence. Eur J Cardiovasc Prev Rehabil. 2007; 15: 306–11.
  23. Sniehotta FF, Scholz U, Schwarzer R, Fuhrmann B, Kiwus U, Voller H. Long-term effects of two psychological interventions on physical exercise and self-regulation following cardiac rehabilitation. Int J Behav Med 2005; 12: 244–55.
  24. Koenigsberg MR, Bartlett D, Cramer JS. Facilitating treatment adherence with lifestyle changes in diabetes. Am Fam Phys. 2004; 69: 269–70.
  25. Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, Napoli N, Qualls C, Shah K. Weight Loss, Exercise, or Both and PhysicalFunction in Obese Older Adults N Engl J Med 2011;364:1218-29
  26. Perk J, De Backer G, Gohlke H, Graham I et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2012; 33: 1635–1701.
  27. Mitrou PN, Kipnis V, Thiébaut ACM, Reedy J, Subar AF, Wirfält E, et al. Mediterranean Dietary Pattern and Prediction of All-Cause Mortality in a US Population Results From the NIH-AARP Diet and Health Study. Arch Intern Med. 2007; 167: 2461–8.
  28. Frisoli TM, Schmieder RE, Grodzicki T, and Messerli FH Controversies in cardiovascular medicine Beyond salt: lifestyle modifications and blood pressure European Heart Journal (2011) 32, 3081–3087

Ernährung in der kardiovaskulären Prävention

Clemens von Schacky

 

  1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33: 1635–701
  2. Harcombe Z, Baker JS, Cooper SM, Davies B, Sculthorpe N, DiNicolantonio JJ, Grace F. Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review and meta-analysis. Open Heart. 2015; 2: e000196.
  3. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014; 160: 398–406
  4. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006; 295: 655–66
  5. von Schacky C. Omega-3 index and cardiovascular health. Nutrients. 2014; 6: 799-814
  6. von Schacky C. Omega-3 fatty acids in cardiovascular disease--an uphill battle. Prostaglandins Leukot Essent Fatty Acids. 2015; 92: 41–7
  7. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013; 346: e8707
  8. Bendsen NT, Christensen R, Bartels EM, Astrup A. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr. 2011; 65: 773–83. 
  9. Sun Q, Ma J, Campos H, Hankinson SE, Manson JE, Stampfer MJ, Rexrode KM, Willett WC, Hu FB. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation. 2007; 1 15: 1858–65
  10. Harris WS, Pottala JV, Vasan RS, Larson MG, Robins SJ. Changes in Erythrocyte Membrane Trans and Marine Fatty Acids between 1999 and 2006 in Older Americans. J Nutr. 2012; 142: 1297–303
  11. Harris WS, Pottala JV, Varvel SA, Borowski JJ, Ward JN, McConnell JP. Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: Observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids. 2013; 88: 257–63
  12. Köhler A, Bittner D, Löw A, von Schacky C. Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 2010; 104: 729–36.
  13. Graudal N, Jürgens G, Baslund B, Alderman MH. Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens. 2014; 27: 1129–37.
  14. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens. 2011; 24: 843–53
  15. Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2013; 347: f6879.
  16. Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014; 349: g4490.
  17. von Schacky C. Hirnstruktur und Hirnfunktion: Rolle der Omega-3 Fettsäuren. Z Orthomol Med 2014; 1: 20–4
  18. Haast RA, Kiliaan AJ. Impact of fatty acids on brain circulation, structure and function. Prostaglandins Leukot Essent Fatty Acids. 2015; 92: 3–14
  19. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women. Arch Int Med. 2006; 166: 2437–45
  20. Gonçalves A, Claggett B, Jhund PS, Rosamond W, Deswal A, Aguilar D, Shah AM, Cheng S, Solomon SD. Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. Eur Heart J. 2015; 36: 939 - 45
  21. Zhang C, Qin YY, Chen Q, Jiang H, Chen XZ, Xu CL, Mao PJ, He J, Zhou YH. Alcohol intake and risk of stroke: a dose-response meta-analysis of prospective studies. Int J Cardiol. 2014; 174: 669–77.
  22. Hafekost K, Lawrence D, Mitrou F, O'Sullivan TA, Zubrick SR. Tackling overweight and obesity: does the public health message match the science? BMC Med. 2013; 11: 41.
  23. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Martínez-González MA; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013; 368: 1279–90.
  24. Pilz S, Gaksch M, Hartaigh BÓ, Tomaschitz A, März W. Vitamin D in Preventive Medicine. Anticancer Res. 2015; 35: 1161–1170.
  25. von Schacky C. Sinn und Unsinn. Vitamine und Supplemente in der Kardiologie. Akt Kard 2014; 3: 375–9

Psychologie und Sekundärprävention der Koronaren Herzkrankheit

Dieter Benninghoven

 

  1. Miller WR, Rollnick S. Motivierende Gesprächsführung. Freiburg: Lambertus, 2015.
  2. Miller WR, Rollnick S. Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press, 1991.
  3. Burke BL, Arkowitz H, Menchola M. The Efficacy of Motivational Interviewing: A Meta-Analysis of Controlled Clinical Trials.  Journal of Consulting and Clinical Psychology 2003; 71 (5): 843–861. 
  4. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L, Wu JHC. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 2014. 
  5. Sheridan SL, Draeger LB, Pignone MP, Keyserling TC, Simpson RJ Jr, Rimer B, et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research 2011; 11: 331.
  6. Faller H, Reusch A, Meng K. Innovative Schulungskonzepte in der medizinischen Rehabilitation. Bundesgesundheitsblatt – Gesundheitsforschung, Gesundheitsschutz 2011; 54(4): 444-450.
  7. Reese C, Mittag O, Bengel J, Boll-Klatt A, Cordes C, Deck R, Dräger-Recktenwald R, Faller H, Fleig L, Gauggel S, Geigges W, Grande G, Hautzinger M, Herrmann-Lingen C, Langosch W, Mai B, Niebling W, Pomp S, Schmucker D, Wörner S,  Worringen U Praxisempfehlungen für psychologische Interventionen in der Rehabilitation: Koronare Herzerkrankung, 2012. Zugriff am 09.04.2015. Verfügbar unter www.uniklinik-freiburg.de/aqms/live/Praxisempfehlungen.html
  8. Herrmann-Lingen C. Curriculum psychokardiologische Grundversorgung. Ärztliche Psychotherapie und Psychosomatische Medizin, 2009; 4 (2): 93-94.
  9. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
  10. Meyer T, Hussein S, Lange HW, Herrmann-Lingen C. Anyiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting. European Journal of Preventive Cardiology 2015; 22(1): 75-82.
  11. Lett HS, Blumenthal JA, Babyak MA, Strauman TJ, Robins C, Sherwood A. Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med 2005; 67: 869-878.
  12. Eller NH, Netterstrom B, Gyntelberg F, Kristensen TS, Nielsen F, Steptoe A, Theorell T. Work-related psychosocial factors and the development of ischemic heart disease: a systematic review. Cardiol Rev 2009; 17: 83-97.
  13. Eaker ED, Sullivan LM, Kelly-Hayes M, D’Agostino Sr RB, Benjamin EJ. Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study. Psychosom Med 2007; 69: 509-513.
  14. Denollet J, Gidron Y, Vrints CJ, Conraads VM. Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease. Am J Cardiol 2010; 105: 1555-1560.
  15. Denollet J, Schiffer AA, Spek V. A general propensity to psychological distress affects  cardiovascular outcomes: evidence from research on the type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 2010; 3: 546-557.
  16. Herrmann-Lingen C, Buss U,  Snaith RP. Hospital Anxiety and Depression Scale -- Deutsche Version. Göttingen: Hogrefe, 2011. 
  17. Löwe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brähler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. Journal of Affective Disorders 2010; 12: 86-95.
  18. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 95-699. 
  19. Whalley B, Rees K, Davies P, Bennet P, Ebrahim S, Liu Z, West R, Moxham T, Thompson DR, Taylor RS. Psychological interventions for coronary heart disease. Cochrane Database of Systematic Reviews, Issue 8, 2011.
  20. Orth-Gomér K, Schneiderman N, Wang HX, Walldin C, Blom M, Jernberg T). Stress reduction prolongs life in women with coronary disease The Stockholm Women’s Intervention Trial for Coronary Heart Disease (SWITCHD) Circ Cardiovasc Qual Outcomes 2009; 2: 25-32. 
  21. Bandelow B, Wiltink J, Alpers GW, Benecke C, Deckert J, Eckhardt-Henn A, Ehring C, Engel E, Falkai P, Geiser F, Gerlach AL, Harfst R, Hau S, Joraschky P, Kellner M, Köllner V, Kopp I, Langs G, Lichte T, Liebeck H, Matzat J, Reitt M, Rüddel HP, Rodolf S, Schick G, Schweiger U, Simon R, Springer A, Staats H, Ströhle A, Ströhm W, Waldherr B, Watzke B, Wedekind D, Zottl C, Zwanziger P, Beutel ME. Deutsche Leitlinie Behandlung von Angststörungen, 2014. www.awmf.org/leitlinien.html
  22. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 2010; 170: 600-608.
  23. Bishop GD, Kaur D, Tan VL, Chua YL, Liew SM, Mak KH. Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting. Am Heart J 2005; 150: 602-609.
  24. Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svardsudd K. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med 2011; 171: 134-140.
  25. Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J 2007; 28: 2972-2984.
  26. Klein PJ, Adams WD. Comprehensive therapeutic benefits of Taiji: A critical review.  Am J Phys Med Rehabil 2004; 83: 735–745.
  27. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev; 1: CD003041, 2004.
  28. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz D, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer W, Vrints C, Wood D, Zamorano JL, Zannad F. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). European Journal of Preventive Cardiology 2012; 19(4): 585–667.
  29. Birk T, Kröger C. Rauchfrei nach Hause!? – Kursleitermanual der Klinikversion des Rauchfrei Programms. IFT Institut für Therapieforschung, München, 2010.
  30. Stead LF & Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev; 2: CD001007, 2005.
  31. Lancaster R, Lindsay S, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000; 321(7257): 355-358.

Körperliche Aktivität in Prävention und Sekundärprävention

Birna Bjarnason-Wehrens

 

  1. Hollmann W, Strüder H. Sportmedizin Grundlagen für körperliche Aktivität Training und Präventivmedizin. 5. Völlig neu bearbeitete und erweiterte Auflage. Schattauer, Stuttgart. 2009.
  2. Bachl N, Bauer R, Dorner TE, Gäbler C, Gollner E, et al. (2010). Österreichische Empfehlungen für gesundheitswirksame Bewegung. [Hrsg.] Bundesministerium für Gesundheit, Gesundheit Österreich GmbH und Geschäftsbereich Fonds Gesundes Österreich. Wien.
  3. Global status report on noncommunicable diseases 2014. 1. Chronic Disease - prevention and control. 2. Chronic Disease - epidemiology. 3. Chronic Disease - mortality. 4. Cost of Illness. 5. Delivery of Health Care. I.  World Health Organization. ISBN 978 92 4 156485 4. WHO, Geneva, 2014. (www.who.int)
  4. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990– 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224?60. 
  5. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Impact of Physical Inactivity on the World’s Major Non- Communicable Diseases. Lancet. 2012;380:219–229. 
  6. World Health Organization. Global recommendations on physical activity for health. Geneva, Switzerland: WHO; 2010. 
  7. Franco OH, de Laet C, Peeters A, Jonker J, Mackenbach J, Nusselder W. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med. 2005;165:2355-60. 
  8. Warren TY, Barry V, Hooker SP, Sui X, Church TS, Blair SN. Sedentary behaviors increase risk of cardiovascular disease mortality in men. Med Sci Sports Exerc 2010;42:879-85. 
  9. Bairey Merz CN, Alberts MJ, Balady GJ, Fonseca V, Ballantyne CM, et al. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease). J Am Coll Cardiol 2009;54:1336-63. 
  10. Krug S, Jordan S, Mensink GBM,  Müters S, Finger JD, Lampert T. Körperliche Aktivität Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl 2013;56:765-771.
  11. Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh CC. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986;314:605-13. 
  12. Löllgen H, Böckenhoff A, Knapp G. Physical activity and all-cause mortality: An updated meta-analysis with different intensity categories. Int J Sports Med 2009;30:213-224. 
  13. Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008;15:239-46. 
  14. Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol 2011;40:1382-400. 
  15. Li J, Loerbroks A, Angerer P. Physical activity and risk of cardiovascular disease: what does the new epidemiological evidence show? Curr Opin Cardiol 2013;28:575-83. 
  16. Sofi F, Capalbo A, Cesari F, Abbate R, Gensini GF. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008;15:247-257. 
  17. Sattelmair JR, Perman J, Ding EL, Hohl HW III, Haskell WL, Lee I-M. Dose-response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 2011;124:789-95. 
  18. Shiroma EJ, Lee IM. Physical Activity and Cardiovascular Health Lessons Learned From Epidemiological Studies Across Age, Gender, and Race/Ethnicity. Circulation 2010;122:743-752.
  19. Löllgen H, Löllgen D. Risikoreduktion kardiovaskulärer Erkrankungen durch körperliche Aktivität. Internist 2011;53:20–29.
  20. Hamer M, Chida Y. Walking and primary prevention: a meta-analysis of prospective cohort studies. Br J Sports Med 2008;42:238-243. 
  21. Wen CP, Wai JPM, Tsai MK, Yang YC, Cheng TYD, Lee M-C, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 2011; 378:1244–53. 
  22. Blumenthal JA, Babyak MA, Carney RM, Huber M, Saab PG, Burg MM, et al. Exercise, Depression, and Mortality after Myocardial Infarction in the ENRICHD Trial. Medicine & Science in Sports & Exersise  2004; 746-755; DOI: 10.1249/01.MSS.0000125997.63493.13
  23. Wannamethee SG, Shaper AG, Walker M. Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation 2000;102:1358-63. 
  24. Janssen I, Jolliffe CJ. Influence of physical activity on mortality in elderly with coronary artery disease. Med Sci Sports Exerc 2006;418-23. 
  25. Al-Khalili F, Janszky I, Andersson A, Svane B, Schenck-Gustafsson K. Physical activity and exercise performance predict long-term prognosis in middle-aged women surviving acute coronary syndrome. J Intern Med 2007;261:178-87. 
  26. Moholdt T, Wisløff U, Nilsen TIL, Slørdahl SA. Physical activity and mortality in men and women with coronary heart disease: a prospective population-based cohort study in Norway (the HUNT study). Eur J Cardiovasc Prev Rehabil 2008;15:639-45. 
  27. Apullan FJ, Bourassa MG, Tardif JC, Fortier A, Gayda M, Nigam A. Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease. Am J Cardiol 2008;102:375-79. 
  28. Gerber Y, Myers V, Goldbourt U, Benyamini Y, Scheinowitz M, Drory Y. Long-term trajectory of leisure time physical activity and survival after first myocardial infarction: a population-based cohort study. Eur J Epidemiol 2011;26:109-16. 
  29. Mons U, Hahmann H, Brenner H. A reverse J-shaped association of leisure time physical activity with prognosis in patients with stable coronary heart disease: evidence from a large cohort with repeated measurements. Heart 2014;100:1043-9. 
  30. Yu C, Li LS, Ho HH, Lau C. Long-term changes in exercise capacity, quality of life, body anthropometry, and lipid profiles after a cardiac rehabilitation program in obese patients with coronary heart disease. Am J Card 2003;91:321-5. 
  31. Shibata Y, Hayasaka S, Yamada T, Ojima T, Ishikawa S et al. Physical activity and risk of fatal or non-fatal cardiovascular disease among CVD survivors – The JMS cohort study. Circ J 2011;75:1368-72. 
  32. Bjarnason-Wehrens B, Schulz O, Gielen S, Halle M, Dürsch M et al. Leitlinie körperliche Aktivität zur Sekundärprävention und Therapie kardiovaskulärer Erkrankungen. Clin Res Cardiol 2009;Suppl. 3;1-44. 
  33. Vanhees L, Rauch B, Piepoli M, van Buuren F, Takken T et al. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III). Eur J Prev Cardiol 2012;19:6:1333-56. 
  34. Piepoli MF, Corrà U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: A Policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol 2012;21:6:664-81. 
  35. Steffen-Batey L, Nichaman MZ, Goff DC, Frankowski RF, Hanis CL et al. Change in level of physical activity and risk of all-cause mortality or reinfarction: The Corpus Christi Heart Project. Circulation 2000;102:2204-9. 
  36. Marzolini S, Oh PI, Brooks D. Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease: a meta-analysis. Eur J Prev Cardiol 2012;19:81-94.

 

 

Internetbasierte Nachsorge nach kardiologischer Reha am Beispiel lebensstil-aendern.de

Rebecca Schweier, Matthias Romppel, Cynthia Richter, Gesine Grande

 

  1. Statistisches Bundesamt. Todesursachen in Deutschland: 2013. Wiesbaden; 2014. Fachserie 12 Reihe 4. www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Todesursachen/Todesursachen.html. Letzter Zugriff am 03.03.2015.
  2. Jackson L, Leclerc J, Erskine Y, Linden W. Getting the Most out of Cardiac Rehabilitation: A Review of Referral and Adherence Predictors. Heart. 2005; 91: 10–4.
  3. Haaf H. Ergebnisse zur Wirksamkeit der Rehabilitation. Rehabilitation. 2005; 44: 259–76.
  4. Huy C, Thiel A, Diehm C, Schneider S. Adhärenz-Defizite auf allen Ebenen: Aktueller Interventionsbedarf in der Primär-, Sekundär- und Tertiärprävention kardiovaskulärer Erkrankungen. Dtsch med Wochenschr. 2010; 135: 2119–24.
  5. Küpper-Nybelen J, Rothenbacher D, Hahmann H, Wüsten B, Brenner H. Veränderungen von Risikofaktoren nach stationärer Rehabilitation bei Patienten mit koronarer Herzkrankheit. Dtsch med Wochenschr. 2003: 1525–30.
  6. Völler H, Klein G, Gohlke H, Dovifat C, Binting S, Müller-Nordhorn J, et al. Sekundärprävention Koronarkranker nach stationärer Rehabilitation. Dtsch med Wochenschr. 2000; 125: 1457–61.
  7. Sterdt E, Brandes I, Dathe R, Walter U. Nachsorge im Rahmen der kardiologischen Rehabilitation – Ansätze von Prävention und Gesundheitsförderung. Rehabilitation. 2010; 49: 87–94.
  8. Hahmann HW. Kardiologische Rehabilitation: Aktueller Stand und zukünftige Anforderungen. Herz. 2012; 37: 22–9.
  9. Griffiths F, Lindenmeyer A, Powell J, Lowe P, Thorogood M. Why Are Health Care Interventions Delivered Over the Internet? A Systematic Review of the Published Literature. J Med Internet Res. 2006; 8: e10.
  10. Keck M. Intensivierte Nachsorge zur Verbesserung der kardiovaskulären Risikofaktoren sowie anderer relevanter Reha-Outcomes bei Patienten mit manifester koronarer Herzerkrankung mittels Telefonnachsorge. In: 18. Rehabilitationswissenschaftliches Kolloquium. Berlin; 2009. 357–8. 
  11. Blasco A, Carmona M, Fernández-Lozano I, Salvador CH, Pascual M, Sagredo PG, et al. Evaluation of a Telemedicine Service for the Secondary Prevention of Coronary Artery Disease. J Cardiopulm Rehabil Prev. 2012; 32: 25–31.
  12. Theissing J, Deck R, Raspe H. Liveonline-Nachbetreuung bei Patienten mit abdominaler Adipositas in der kardio-diabetologischen Rehabilitation: Ergebnisse einer randomisierten, kontrollierten Studie. Rehabilitation. 2013; 52: 153–4.
  13. Lin J, Ebert DD, Lehr D, Berking M, Baumeister H. Internetbasierte kognitiv-behaviorale Behandlungs­ansätze: State of the Art und Einsatzmöglichkeiten in der Rehabilitation. Rehabilitation. 2013; 52: 155–63.
  14. Kotseva K, Wood D, Backer G de, Bacquer D de. Use and Effects of Cardiac Rehabilitation in Patients with Coronary Heart Disease: Results from the EUROASPIRE III Survey. Eur J Prev Cardiol. 2013; 20: 817–26.
  15. Bandura A. Sozial-kognitive Lerntheorie. Stuttgart: Klett-Cotta; 1979.
  16. Kohl LFM, Crutzen R, Vries NK de. Online Prevention Aimed at Lifestyle Behaviors: A Systematic Review of Reviews. J Med Internet Res. 2013; 15: e146.
  17. Webb TL, Joseph J, Yardley L, Michie S. Using the Internet to Promote Health Behavior Change: A Systematic Review and Meta-Analysis of the Impact of Theoretical Basis, Use of Behavior Change Techniques, and Mode of Delivery on Efficacy. J Med Internet Res. 2010; 12: e4.
  18. Wantland JD, Portillo JC, Holzemer LW, Slaughter R, McGhee ME. The Effectiveness of Web-Based vs. Non-Web-Based Interventions: A Meta-Analysis of Behavioral Change Outcomes. J Med Internet Res. 2004; 6: e40.
  19. Grunenberg E, Lin J, Baumeister H. Wirksamkeit web-basierter psychologischer Interventionen zur Gewichtsreduktion – ein systematisches Review. Rehabilitation. 2013; 52: 182–7.
  20. Neve M, Morgan PJ, Jones PR, Collins CE. Effectiveness of Web-based Interventions in Achieving Weight Loss and Weight Loss Maintenance in Overweight and Obese Adults: A Systematic Review with Meta-Analysis. Obes Rev. 2010; 11: 306–21.
  21. Bossen D, Veenhof C, Dekker J, Bakker D de. The Effectiveness of Self-Guided Web-Based Physical Activity Interventions among Patients with a Chronic Disease: A Systematic Review. J Phys Activ Health. 2014; 11: 665–77.
  22. Eimeren B van, Frees B. 79 Prozent der Deutschen online – Zuwachs bei mobiler Internetnutzung und Bewegtbild: Ergebnisse der ARD/ZDF-Onlinestudie 2014. Media Perspektiven. 2014: 378–96.
  23. Lausen B, Potapov S, Prokosch H. Gesundheitsbezogene Internetnutzung in Deutschland 2007. GMS Med Inform Biom Epidemiol. 2008; 4: Doc06.
  24. Kontos E, Blake KD, Chou WS, Prestin A. Predictors of eHealth Usage: Insights on the Digital Divide from the Health Information National Trends Survey 2012. J Med Internet Res. 2014; 16: e172.
  25. Neter E, Brainin E. eHealth Literacy: Extending the Digital Divide to the Realm of Health Information. J Med Internet Res. 2012; 14: e19.
  26. Fox S, Purcell K. Chronic Disease and the Internet. Washington, D.C.: Pew Research Center; 24.03.2010. pewinternet.org/Reports/2010/Chronic-Disease.aspx. Letzter Zugriff am 18.11.2013.
  27. Friedrichsen M, Schachinger A. Was machen 40 Millionen deutsche Gesundheits-Surfer und Patienten im Internet? Pressemappe zur E-Patienten Studie 2014 in Deutschland; 2014. bundesverbandinternetmedizin.de/wp-content/uploads/2014/04/E-Patienten_Studie_2014_Pressemappe1.pdf. Letzter Zugriff am 08.10.2014.
  28. Gößwald A, Schienkiewitz A, Nowossadeck E, Busch M. Prävalenz von Herzinfarkt und koronarer Herzkrankheit bei Erwachsenen im Alter von 40 bis 79 Jahren in Deutschland: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl. 2013; 56: 650–5.
  29. Ohlow M, Brunelli M, Lauer B. Internet Use in Patients with Cardiovascular Diseases: Bad Berka Cross-Sectional Study (BABSY). Int J Clin Pract. 2013; 67: 990–5.
  30. Neubeck L, Ascanio R, Bauman A, Briffa T, Clark AM, Freedman B, et al. Planning Locally Relevant Internet Programs for Secondary Prevention of Cardiovascular Disease. Eur J Cardiovasc Nurs. 2011; 10: 213–20.
  31. Pietrzak E, Cotea C, Pullman S. Primary and Secondary Prevention of Cardiovascular Disease: Is there a Place for Internet-based Interventions? J Cardiopulm Rehabil Prev. 2014; 34: 303–17.
  32. Munro J, Angus N, Leslie SJ. Patient Focused Internet-Based Approaches to Cardiovascular Rehabilitation – a Systematic Review. J Telemed Telecare. 2013; 19: 347–53.
  33. Devi R, Igbinedion E, Powell J, Singh S, Rees K. Internet Based Interventions for the Secondary Prevention of Coronary Heart Disease: Protocol. The Cochrane Library. 2011.
  34. Michel A, Wilke K, Stamm-Balderjahn S, Spyra K. Akzeptanzanalyse für die Nutzung des Internetportals herzwegweiser.de durch Rehabilitanden und Fachkreise. In: 24. Rehabilitationswissenschaftliches Kolloquium; 2015 [in Druck]. 
  35. Stamm-Balderjahn S. Ein Jahr herzwegweiser.de – Über 50.000 Seitenaufrufe. 2015. www.herzwegweiser.de/aktuelles/artikel/detail/1-jahr-herzwegweiserde-ueber-50000-s/. Letzter Zugriff am 23.02.2015.
  36. Dohndorf O, Göring A, Krumm H, Schneider A, Sommer A, Sladek S, et al. RehaWeb – Ein Informationssystem zur Unterstützung der kardiologischen Rehabilitation in der 3. Phase. In: Technik für ein selbstbestimmtes Leben (AAL 2012): Tagungsbeiträge. Berlin, Offenbach: VDE Verlag; 2012. 
  37. Becker J, Gerzymisch K, Beutel M, Zwerenz R. Entwicklung und Evaluation einer indikationsübergreifenden internetbasierten Nachsorgemaßnahme zur Verbesserung der beruflichen Reintegration (GSA-Online): Abschlussbericht. Mainz; 2014.
  38. Richter C, Schweier R, Romppel M, Grande G. Erfolgreiche Peers als Modell. Ein internetbasiertes Unterstützungsangebot zur nachhaltigen Lebensstilmodifikation. Phys Rehab Kur Med. 2013; 23: 283–91.
  39. Schweier R, Romppel M, Richter C, Hoberg E, Hahmann H, Scherwinski I, et al. A Web-Based Peer-Modeling Intervention Aimed at Lifestyle Changes in Patients With Coronary Heart Disease and Chronic Back Pain: Sequential Controlled Trial. J Med Internet Res. 2014; 16: e177.
  40. Schweier R, Richter C, Grande G. Abschlussbericht zum Projekt „lebensstil-aendern.de – Videogestützte Internetplattform zur Unterstützung einer nachhaltigen Lebensstilmodifikation im Alltag“. Leipzig: Hochschule für Technik, Wirtschaft und Kultur Leipzig; 2014.
  41. Schweier R, Romppel M, Richter C, Grande G. Predictors of Coronary Heart Disease Patients’ Usage of a Web-based Intervention Aimed at Lifestyle Change. Results from lebensstil-aendern.de: European Congress on e-Cardiology & e-Health October 2014, Selected Abstracts. Eur J Prev Cardiol. 2014; 21: 40.